Advertisement

Topics

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

19:00 EST 16 Feb 2017 | Alzheimer's Research and Therapy

Despite substantial research and development investment in Alzheimer’s disease (AD), effective therapeutics remain elusive. Significant emerging evidence has linked cholesterol, β-amyloid and AD, and several s...

Original Article: Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

NEXT ARTICLE

More From BioPortfolio on "Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...